Remala Abadi Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp1,920 (market cap 2.61T, 681.2K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 10.67M 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 16.2× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (10.67M versus 681.2K). Which is the better fit depends on your goals.
| DATA | DKHH | |
|---|---|---|
Market Cap | 2.61T | 160.67B |
Volume | 681.2K | 10.67M |
Lot | 6.81K | 106.74K |
Turnover | 1.3B | 663.84M |
Average Price | 1,906.68 | 62.19 |
Value | 1.3B | 663.84M |
Indicative Equilibrium Price | 1,920 | 63 |
Indicative Equilibrium Volume | 72 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →